Skip to main content

Table 2 Clinical features according to HPV type

From: Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia

 HPV 16HPV 18HPV 52HPV 58Other hrHPVsNegativep-value
Age (years)37 ± 0.939 ± 3.638 ± 0.839 ± 1.044 ± 1.240 ± 1.70.001*1
Months since diagnosis40 ± 5.238 ± 10.036 ± 4.439 ± 5.137 ± 7.237 ± 7.00.95*1
Smoking (%)15/55 (27.3)3/10 (30.0)14/56 (25.0)19/56 (28.4)16/72 (22.2)7/39 (18.0)0.57*2
Parity ≥1 (%)23/57 (40.3)3/10 (30.0)23/56 (41.1)22/57 (38.6)26/74 (35.1)15/40 (37.5)0.97*2
Steroid use (%)0/59 (0.0)0/10 (0.0)2/57 (3.5)2/58 (3.5)2/74 (2.7)1/36 (2.8)0.56*2
  1. Clinical features were summarized according to HPV categorize. HPVs 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68 were classified as hrHPVs. Of these, HPV 16, 18, 52, and 58 were categorized separately. hrHPVs other than HPVs 16, 18, 52, and 58 were classified as “other hrHPVs.” Patients who were not infected with any hrHPVs were referred to as “no hrHPVs” patients. Statistical analysis was performed using a Steel-Dwass test (*1) and the Analysis of Variance (*2)
  2. HPV human papillomavirus